In response to America's national opioid abuse epidemic, electronic prescribing of controlled substances (EPCS) continues to gain momentum among federal and state lawmakers to reduce "doctor shopping" and minimize the risk of altered, stolen, or fraudulent prescriptions. In October 2018, the SUPPORT for Patients and Communities Act was signed into federal law by President Trump. Included in the bill is an electronic prescribing requirement for all controlled substance prescriptions for a covered part D drug under a prescription drug plan (or an MA-PD plan). The deadline to comply is January 1, 2021.
In addition to the federal mandate, many states are implementing similar laws. New York became the first state to mandate EPCS in 2016. Since then, many additional states have passed similar legislation or are considering proposed mandates. At the current time, Delaware, West Virginia, and Louisiana do not have any regulations pending. Pennsylvania mandatory EPCS will begin on 10/24/19 and New Jersey will begin on 5/1/20.
There are MIPS Improvement Activities and Promoting Interoperability measures that involve prescription drug monitoring programs (PDMPs). Doesn't it make sense to focus on PDMP now even if it is not mandatory in your state yet?